Citadel Advisors »

Briacell Therapeutics Corp shares owned by Citadel Advisors

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $205k 35k 5.85

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Briacell Therapeutics Corp

Lynwood Capital Management
Torno Capital
Redmond Asset Management
K.J. Harrison & Partners
Bank Of Montreal
Onyx Bridge Wealth Group
Summit Trail Advisors
Citadel Advisors
Royal Bank of Canada
Bank of America Corporation
HighTower Advisors
TD Waterhouse Canada
Concord Wealth Partners
National Bank Of Canada /fi/
UBS Group

View all funds holding Briacell Therapeutics Corp